Anellotech and Suntory strengthen their alliance for development and commercialization of biobased PET bottles
Type of post: NEWS IN BRIEF.
Anellotech
is a sustainable technology company focused on the production of bio-aromatics.
This month, it made two important announcements regarding to its Bio-TCat
process, which is aimed to produce cost-competitive renewable aromatic
chemicals (benzene, toluene and xylenes, “BTX”) from non-food biomass for use
in manufacturing plastics (polyester, nylon, polycarbonate, polystyrene) or for
renewable transportation fuels.
On the one hand, Anellotech announced that
Japan-based Suntory Holdings Limited, one of the world’s leading
consumer beverage companies, has invested an additional 9 M$ in its Bio-TCat
technology (see press release, 18/1/2018). This latest tranche, which
is part of a new 15 M$ package based on Anellotech achieving specific
milestones, brings Suntory’s total investment in the renewable chemicals company
to more than 25 M$ to date. This alliance began in 2012 with the goal of
enabling the development and commercialization of cost-competitive 100% biobased
plastics for use in beverage bottles. Suntory currently uses 30% plant-derived
materials for its Mineral Water Suntory Tennensui brands and is pursuing the
development of a 100% bio-based PET bottle through this alliance.
Figure 1. TCat-8 pilot plant (extracted from
the web site of Anellotech)
On the other hand, the company reported the
completion of the commissioning of its 25 meter tall TCat-8 pilot plant and the
starting of a critical development program to validate process economics and
obtain necessary data for commercial plant design (see press release, 4/1/2018). The pilot plant was jointly designed
by Anellotech and IFPEN and is located in Silsbee (Texas, USA) on the
plant site of South Hampton Resources (SHR). The process will use a novel catalyst under
joint development by Anellotech and Johnson
Matthey. The program will
generate bio-BTX samples for use in making PET for Suntory packaging and polymers
such as ABS, polycarbonate and polyurethane for other strategic investors. Commercial
Bio-TCat™ plant design and process licensing will be carried-out by Axens.